| |
    
  
|
|
  
  |
|
|
2006 News Releases
- News Release - December 27, 2006
Pandemic preparedness project to receive
$1 million funding through Rx&D's new and enhanced Health
Research Foundation.
- News Release Read
more
- To view the video statement in French of Dr. Yves
Morin, President of the Rx&D HRF, click
here
- To view the video statement in English of Mr. John
Suk, Vice-Chair of the Rx&D HRF, click
here
- News Release - December 8, 2006
An International Comparison Study shows Canada’s Common
Drug Review is a barrier to access to new medicines for
patients.
- Statement - December 5, 2006
Rx&D reacts to the unveiling of the new Quebec research
and innovation strategy. Read
more
- News Release - November 28, 2006
More improvements to the Rx&D Code of Conduct. Read
more
- News Release - November 28, 2006
Rx&D Board Chairman Philip Blake inducted into the Canadian
Healthcare Marketing Hall of Fame, November 28, 2006. Read
more
- Letter-to-the-Editor - November 27, 2006
The Victoria Times Colonist published a letter to the editor
by Rx&D President Russell Williams responding to an
editorial on the recent changes to data protection regulations
approved by the federal government. Read
more
- Statement - November 24, 2006
Rx&D welcomes science and technology initiative in the
Economic Statement by Federal Finance Minister Jim Flaherty.
Read
more
- News Release - November 15, 2006
Mr. Philip Blake is the new Chairman of Rx&D's Board
of Directors. Read
more
- News Release and Speeches - November 14, 2006
Rx&D and Health Partners International of Canada (HPIC)
sign a formal agreement for the delivery of medicines to
the developing world.- Read
more
Speeches:
- Russell Williams, President of Rx&D - Read
more
- The Honourable Jake Epp, P.C., Chairman of HPIC -
Read
more
- John Kelsall, President of HPIC - Read
more
- Paul Lucas, Chairman of Rx&D, and President and
CEO of GlaxoSmithKline - Read
more
- Op-Ed - November 13, 2006
Rx&D President Russell Williams on data protection in
The Hill Times: A winning policy for research, innovation
and patients. Read
more
- Speech - November 9, 2006
Rx&D President Russell Williams introduces President
Bill Clinton at the Montreal Millenium Conference 2006.
Read
more
- Media Advisory - November 9, 2006
Joint news conference by Canada’s Research-Based
Pharmaceutical Companies (Rx&D) and Health Partners
International of Canada (HPIC). Read
more
- Speech - October 24, 2006
Paul Lucas, President and CEO of GlaxoSmithKline Canada,
addressed the Economic Club of Toronto on the sustainability
of the life sciences sector in Ontario. Read
more
- Letter-to-the-Editor - October 26, 2006
The Ottawa Citizen, The Montreal Gazette, The Winnipeg Free
Press and the Saskatoon StarPhoenix published a letter to
the editor from Rx&D President Russell Williams on the
importance of data protection for patients and innovation
in Canada.
- News Release - October 25, 2006
Rx&D encourages Canada to renew the conditions that
foster its success in pharmaceutical innovation. Read
more
- Speech - October 25, 2005
Presentation to the House of Commons Standing Committee
on Finance Pre-Budget Consultations held in Quebec City.
Read
more
- Statement - October 18, 2006
New Data Protection Rules Mean New Therapies for Canadians.
Read
more
- Op-Ed - October 9, 2006
Exploring new frontiers with Quebec’s Drug Policy,
says Russell Williams, President of Rx&D, in the Montreal
Gazette. Read
more
- Statement - September 21, 2006
Statement from Russell Williams, President of Rx&D,
on the National Pharmaceuticals Strategy Progress Report.
Read
more
- News Release - September 14, 2006
Rx&D: a partner of the Montreal InVivo Career Fair.
Read
more
- Statement - August 23, 2006
Ontario's Bill 102- An Urgent Call for Changes Before Implementation.
Read
more
- Submission - August 22, 2006
Submission to the Ontario Government on Bill 102 Proposed
Regulations. Read
more
- Letter-to-the-Editor - August 4, 2006
The Toronto Star published a letter to the editor from Rx&D
President Russell Williams, on the concerted, ongoing efforts
of Canada's Research-Based Pharmaceutical Companies (Rx&D)
to fight against HIV/AIDS and disease in the developing
world. Read
more
- Letter-to-the-Editor - July 8, 2006
The Telegraph-Journal (N-B) published a letter to the editor
from Rx&D President Russell Williams. New medicines
are a vital part of the solution to a sustainable and cost-effective
health-care system writes Mr. Williams. Read
more
- Letter-to-the-Editor - June 28, 2006
The Toronto Star published a letter to the editor from Rx&D
President Russell Williams to set the record straight about
the role our community plays in health-care reform in Ontario.
Read
more
- Letter-to-the-Editor - June 24,
2006
The Globe and Mail published a letter to the editor from
Rx&D President Russell Williams on investments in research
and development in Canada. Read
more
- Statement - June 23, 2006
Statement from Rx&D President Russell Williams on the
release of the Patented Medicine Prices Review Board Report
(PMPRB) 2005. Read
more
- Working Together for Paediatric Research - June
22, 2006
Canadian Association of Paediatric Health Centres
(CAPHC) receives $17,500 from Rx&D. Read
more
- News Release - June 14, 2006
The International Federation of Pharmaceutical Manufacturers
& Associations (IFPMA) updates its global marketing
Code.
Read
More
- Letter-to-the-Editor - June 12, 2006
La Voix de l'Est newspaper (Granby, Quebec) published a
letter to the editor from Rx&D President Russell Williams
in which he describes the importance of patent protection,
and the benefits new medicines and vaccines bring to our
health-care system..…
Read More (document available in French only)
- Bill 102 - June 5, 2006
Submission to the Standing Committee on Social Policy, Legislative
Assembly of Ontario on Bill 102, An Act to amend the Drug
Interchangeability and Dispensing Fee Act and the Ontario
Drug Benefit Act. Read
More
- Presentation - June 5, 2006
Rx&D President, Russell Williams, presented before the
Ontario Legislative Standing Committee on Social Policy
regarding Bill102,The Transparent Drug System for Patients
ActMORE
- Speech - June 5, 2006
Rx&D President, Russell Williams, addressed the Economic
Club of Toronto on the impact Bill 102 in Ontario could
have on patients and pharmaceutical research.
Read
More
- News Release - May 29, 2006
Improving Bill 102: A prescription for Patients and Innovation.
Read
More
- Letter-to-the-Editor - May 24, 2006
The Toronto Star published a Letter-to-the-Editor from Russell
Williams, President of Rx&D, on the number of breakthrough
medicines approved in Canada since 1999. Read
More
- News Release - May 11, 2006
CIHI Report confirms patients wait longer for access to
new medicines. Read
More
- News Release - May 3, 2006<
Federal Budget 2006: Enhancing innovation through productivity
and competitiveness. Read
More
- Speech - April 27, 2006
Paul Lucas, Chairman of the Board of Rx&D and President
and CEO of GlaxoSmithKline Inc., addressed the Mississauga
Board of Trade on Bill 102 and its impact on patients and
innovation in Ontario. Read
More
- Expert Panel on Commercialization: "People
and Excellence: The Heart of Successful Commercialization"
- April 24 2006
Statement from Russell Williams, president
of Canada's Research-Based Pharmaceutical Companies
(Rx&D) in response to the release of the report on commercialization
called People and Excellence: The Heart of Successful Commercialization. Read
More
- Transparent Drug System for Patients Act - April
13, 2006
Statement from Canada's Research-Based Pharmaceutical
Companies (Rx&D) regarding the Transparent Drug
System for Patients Act announced by Ontario's Minister
of Health and Long-Term Care George Smitherman on April
13, 2006. Read
More
- Web Cast - April 9, 2006
Mayors' Panel in Chicago at BIO 2006. Click
here to listen
- News Release - April 5, 2006
Speech from the Throne: health innovation includes pharmaceutical
innovation. Read
More
- Letter-to-the-Editor - March 27, 2006
The Winnipeg Free Press published a letter from
Rx&D president Russell Williams on investing in new
medicines and their positive effects on the health care
system. Read
More
- Letter-to-the-Editor - March 27, 2006
The Edmonton Sun published a letter from Rx&D
president Russell Williams on investing in new medicines
and their positive effects on the health care system. Read
More
- Letter-to-the-Editor - March 27, 2006
Letter sent to The Vancouver Sun by Rx&D president
Russell Williams on the fact that health care reforms should
centre on ensuring access to treatment when we need it and
where we live. Read
More
- News Release - March 24, 2006
Ontario Budget - jobs and innovation offer the best of prescription
for health and prosperity. Read
More
- News Release - March 24, 2006
Budget: Pharmaceutical innovation, development tool of collective
wealth for patients and Quebec. Read
More
- Alberta's Consultations on the Health Policy Framework
- March 23, 2006
Statement from Canada's Research-Based Pharmaceutical
Companies (Rx&D) following a meeting with
Alberta's Minister of Health and Wellness, Iris Evans on
March 23, 2006.
Read More
- Op-Ed - March 22, 2006
Innovation must be a priority for the Ontario government
says Russell Williams, president of Rx&D. Read
More
- Op-Ed - March 22, 2006
Quebec's new drug policy should be aligned with the economic
development strategy of the province says Russell Williams,
president of Canada's Research-Based Pharmaceutical Companies
(Rx&D). Read
More
- News Release - March 22, 2006
The International Federation of Pharmaceutical Manufacturers
& Associations (IFPMA) launched a First Worldwide Clinical
Trials Portal: more transparency for patients and healthcare
professionals. Read
more
- News Release - March 15, 2006
IMS Report: Patients are Waiting Longer to Access
New Medicines in Canada. Read
more
- Speech - March 14, 2006
André Marcheterre, President, Merck Frosst Canada
Ltd., gave a speech on the importance of a competitive environment
to maintain a strong research-based pharmaceutical community
in Canada. In French only. Read
more
- Letter-to-the-Editor - February 14, 2006
The Times & Transcript published a Letter-to-the-Editor
from Russell Williams, President of Rx&D, on the value
of new medicines in our health care system. Read
more
- Saying Yes to Innovation - January 30, 2006
Rx&D's Pre-Budget submission to the Standing Committee on
Finance and Economic Affairs Ontario.. Read
more
|
|
|
|
|